SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001723128-18-000037
Filing Date
2018-11-07
Accepted
2018-11-07 16:51:41
Documents
113
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amrx-09x30x201810qdoc.htm 10-Q 1989180
2 EXHIBIT 31.1 amrx-09x30x2018x10qxex311s.htm EX-31.1 24670
3 EXHIBIT 31.2 amrx-09x30x2018x10qxex312r.htm EX-31.2 22800
4 EXHIBIT 32.1 amrx-09x30x2018x10qxex321s.htm EX-32.1 10134
5 EXHIBIT 32.2 amrx-09x30x2018x10qxex322x.htm EX-32.2 9291
  Complete submission text file 0001723128-18-000037.txt   12554178

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT amrx-20180930.xml EX-101.INS 2804309
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amrx-20180930.xsd EX-101.SCH 93325
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amrx-20180930_cal.xml EX-101.CAL 148018
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amrx-20180930_def.xml EX-101.DEF 508656
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amrx-20180930_lab.xml EX-101.LAB 1165794
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amrx-20180930_pre.xml EX-101.PRE 725015
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38485 | Film No.: 181167042
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1